watch the video again...it's the TMPRSS2 protein entry point that's the problem...the data shown in the graphs make it clear...HCQ can't stop viral infection and spreading in human lung cells because of TMPRSS2. HCQ was only tested "In Vitro" on 'Kidney Cells' that don't contain TMPRSS2...so if you want to protect kidneys, maybe that drug is okay, but if you want to keep people off ventilators and dying, it won't help at all...sorry to break this to you.
Oh, and btw, when it comes to a comparison with PAXLOVID, that drug messes up the RNA 'snipping'...essential for spreading... and also has an additional drug to keep that function going much longer...again, proven to be a great drug...HCQ isn't even in the same league...I'm sure I can find the video on that one if you'd like.
Show the video to Dr. Risch...tell me what he has to say about it.
Bottom Line: HCQ...CAN'T WORK against COVID-19...it doesn't have the means of protecting human lung cells.